British Airways: New DVT Study

British Airways has teamed up with the University of Birmingham Medical School in a new research project aimed at examining awareness of deep vein thrombosis (DVT) amongst regular air travellers.

The airline is approaching 1,000 of its most frequent flyers to help researchers from the university’s Public Health and Epidemiology department.

The research study will examine the passengers’ awareness of DVT and any precautionary measures they are taking to reduce their exposure to the condition.

British Airways is currently involved with the World Health Organisation (WHO) in the development of a broad research programme that intends to look at all aspects of travellers’ thrombosis and air travel.

Dr David Flower, one of the airline’s senior consultant occupational physicians, said: “We have accumulated a great deal of knowledge and experience about the effects of air travel on the body helping us to develop a ‘well being’ programme designed to enhance passenger comfort before, during and after flying.


“Travellers’ thrombosis is clearly an issue for which many air travellers have concerns. As an airline, we believe that more research and a greater understanding of the issues surrounding the condition will be of benefit to everyone. Hence, whilst discussions continue with the WHO, we have agreed to assist the University of Birmingham Medical School.”

Dr John Townend, consultant cardiologist at University Hospital Birmingham, is supervising the project. He said: “This is an important piece of work in an area where there is, as yet, little published research. It is important to establish the current level of awareness of DVT amongst those who fly frequently and particularly the level of precautions being taken by experienced air travellers.”